Windlas Biotech Ltd.

NSE: WINDLAS | BSE: 543329 | ISIN: INE0H5O01029 | Industry: Pharmaceuticals
| Mid-range Performer

841.20
4.41%
Prabhudas Lilladhar
experience in manufacturing (solid/ liquid) multiple dosage offers a comprehensive range of CDMO services in India. Over time Windlas evolved and 6) strong financial performance with experienced management. It owns...
Windlas Biotech has gained 11.91% in the last 1 Week
More from Windlas Biotech Ltd.
Recommended